$19.58
-1.22-5.87%
At close: -
$19.26
-0.32-1.63%
After Hours: 9:30 AM EDT
Comments
Loading...
Genmab (NASDAQ:GMAB) Stock, Earnings Estimates, EPS, And Revenue
Genmab reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 12
EPS Estimate
$0.390
Quarterly Revenue Estimate
$886.73M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$19.84B
Analyze the earnings history of Genmab using advanced sorting and filters.
Data brought to you by Benzinga APIs
Genmab (GMAB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-06 | $0.29 | $0.35 | -17.1 % |
| Q2 | 2024-08-08 | $0.31 | $0.33 | -6.06 % |
| Q1 | 2024-05-02 | $0.29 | $0.14 | 107.1 % |
| Q4 | 2024-02-14 | $0.36 | $4.02 | -91.0 % |
Genmab (GMAB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-06 | $816.01M | $828.46M | -1.50 % |
| Q2 | 2024-08-08 | $779.51M | $733.18M | 6.32 % |
| Q1 | 2024-05-02 | $600.43M | $577.46M | 3.98 % |
| Q4 | 2024-02-14 | $675.05M | $679.55M | -0.66 % |
FAQ
When is Genmab (NASDAQ:GMAB) reporting earnings?
Genmab (GMAB) is scheduled to report earnings on February 12, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
What were the latest earnings per share (EPS) for Genmab (NASDAQ:GMAB)?
The Actual EPS was $0.29, which missed the estimate of $0.35.
What were Genmab’s (NASDAQ:GMAB) revenues?
The Actual Revenue was $816M, which missed the estimate of $828.5M.
Browse earnings estimates, EPS, and revenue on all stocks.